Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):
Earnings: $3.24 million in Q3 vs. -$1.85 million in the same period last year.
EPS: $0.03 in Q3 vs. -$0.04 in the same period last year.
Analysts projected $0.06 per share
Revenue: $17.96 million in Q3 vs. $10.35 million in the same period last year.
For comments and feedback: editorial@rttnews.com